Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F3C81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,003
Award facts
- Contract value 100% obligated
- $34,003.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $34,003.09 delivery order to Amerisourcebergen Drug Corp on May 29, 2026, for Dupixent 300 mg/2 ml pen injectable medication.
The order is a firm fixed-price call against the DLA Troop Support Medical indefinite delivery contract supporting the Pharmaceutical Prime Vendor Global Program. Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion on June 1, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F3C81?
SPE2DR26F3C81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 29, 2026.
How much is contract SPE2DR26F3C81 worth?
The government has obligated $34,003 on SPE2DR26F3C81.
Is contract SPE2DR26F3C81 an order under another contract?
Yes. SPE2DR26F3C81 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F3C81 competed?
The extent of competition for SPE2DR26F3C81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award